These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 37144543)

  • 1. A Review of Extracellular Vesicles in COVID-19 Diagnosis, Treatment, and Prevention.
    Su P; Wu Y; Xie F; Zheng Q; Chen L; Liu Z; Meng X; Zhou F; Zhang L
    Adv Sci (Weinh); 2023 Jul; 10(19):e2206095. PubMed ID: 37144543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and Extracellular Vesicles: An Intriguing Interplay.
    Pocsfalvi G; Mammadova R; Ramos Juarez AP; Bokka R; Trepiccione F; Capasso G
    Kidney Blood Press Res; 2020; 45(5):661-670. PubMed ID: 32957112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention.
    Machhi J; Shahjin F; Das S; Patel M; Abdelmoaty MM; Cohen JD; Singh PA; Baldi A; Bajwa N; Kumar R; Vora LK; Patel TA; Oleynikov MD; Soni D; Yeapuri P; Mukadam I; Chakraborty R; Saksena CG; Herskovitz J; Hasan M; Oupicky D; Das S; Donnelly RF; Hettie KS; Chang L; Gendelman HE; Kevadiya BD
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):270-288. PubMed ID: 33544324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2.
    Chen X; Li H; Song H; Wang J; Zhang X; Han P; Wang X
    J Extracell Vesicles; 2022 Dec; 11(12):e12288. PubMed ID: 36450704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles as a Translational Approach for the Treatment of COVID-19 Disease: An Updated Overview.
    Serretiello E; Ballini A; Smimmo A; Acunzo M; Raimo M; Cantore S; Di Domenico M
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19.
    Motallebnezhad M; Omraninava M; Esmaeili Gouvarchin Ghaleh H; Jonaidi-Jafari N; Hazrati A; Malekpour K; Bagheri Y; Izadi M; Ahmadi M
    Pathol Res Pract; 2023 Jan; 241():154280. PubMed ID: 36580795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients.
    Sun R; Cai Y; Zhou Y; Bai G; Zhu A; Kong P; Sun J; Li Y; Liu Y; Liao W; Liu J; Cui N; Xiang J; Li B; Zhao J; Wu D; Ran P
    Front Immunol; 2023; 14():1052141. PubMed ID: 37251406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Extracellular Vesicles in COVID-19 Pathology.
    Tahyra ASC; Calado RT; Almeida F
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword?
    Xia X; Yuan P; Liu Y; Wang Y; Cao W; Zheng JC
    Immunology; 2021 Aug; 163(4):416-430. PubMed ID: 33742451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update.
    Hernández-Díazcouder A; Díaz-Godínez C; Carrero JC
    Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2131-2141. PubMed ID: 36917275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Significance of Phenotyping and Quantification of Plasma Extracellular Vesicles Levels Using High-Sensitivity Flow Cytometry during COVID-19 Treatment.
    Kudryavtsev I; Kalinina O; Bezrukikh V; Melnik O; Golovkin A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications.
    Wang L; Wang D; Ye Z; Xu J
    Adv Sci (Weinh); 2023 Jun; 10(17):e2300552. PubMed ID: 37080941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites.
    Alzahrani FA; Shait Mohammed MR; Alkarim S; Azhar EI; El-Magd MA; Hawsawi Y; Abdulaal WH; Yusuf A; Alhatmi A; Albiheyri R; Fakhurji B; Kurdi B; Madani TA; Alguridi H; Alosaimi RS; Khan MI
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of engineered extracellular vesicles loaded quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: A prospective review.
    Raghav A; Giri R; Agarwal S; Kala S; Jeong GB
    Front Immunol; 2022; 13():1040027. PubMed ID: 36569877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2.
    Park JH; Choi Y; Lim CW; Park JM; Yu SH; Kim Y; Han HJ; Kim CH; Song YS; Kim C; Yu SR; Oh EY; Lee SM; Moon J
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19.
    Moraes ECDS; Martins-Gonçalves R; da Silva LR; Mandacaru SC; Melo RM; Azevedo-Quintanilha I; Perales J; Bozza FA; Souza TML; Castro-Faria-Neto HC; Hottz ED; Bozza PT; Trugilho MRO
    Front Cell Infect Microbiol; 2022; 12():926352. PubMed ID: 35937696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2.
    El-Shennawy L; Hoffmann AD; Dashzeveg NK; McAndrews KM; Mehl PJ; Cornish D; Yu Z; Tokars VL; Nicolaescu V; Tomatsidou A; Mao C; Felicelli CJ; Tsai CF; Ostiguin C; Jia Y; Li L; Furlong K; Wysocki J; Luo X; Ruivo CF; Batlle D; Hope TJ; Shen Y; Chae YK; Zhang H; LeBleu VS; Shi T; Swaminathan S; Luo Y; Missiakas D; Randall GC; Demonbreun AR; Ison MG; Kalluri R; Fang D; Liu H
    Nat Commun; 2022 Jan; 13(1):405. PubMed ID: 35058437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine storms after severe infections.
    Wang Y; Liu S; Li L; Li L; Zhou X; Wan M; Lou P; Zhao M; Lv K; Yuan Y; Chen Y; Lu Y; Cheng J; Liu J
    J Control Release; 2022 Sep; 349():118-132. PubMed ID: 35792186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective.
    Nunez Lopez YO; Casu A; Pratley RE
    Front Immunol; 2021; 12():617042. PubMed ID: 33968019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.